Background: A progressive lung disease and a worse survival have been observed in patients with systemic sclerosis and alveolitis. The objective of this study was to define the functional, radiological and biological markers of alveolitis in SSc patients. Methods: 100 SSc patients ( 76 with limited and 24 with diffuse disease) underwent a multistep assessment of cardiopulmonary system: pulmonary function tests (PFTs) every 6 - 12 months, echocardiography, high resolution computed tomography (HRCT) and bronchoalveolar lavage (BAL), if clinically advisable. Alveolar and interstitial scores on HRCT and IL-6 plasma levels were also assessed as lung disease activity indices. Results: 90 SSc patients with abnormal PFTs and 3 with signs and/or sym...
Objective Interstitial lung disease (ILD ) in systemic sclerosis (SS c) runs a highly variable cours...
Systemic sclerosis (SSc) is a complex, multiorgan, autoimmune disease. Lung fibrosis occurs in ∼80% ...
Purpose: to define clinical prognostic markers for evaluation of inflammation activity and prognosis...
Introduction and aim: Progressive systemic sclerosis (pSS) is a multisystemic connective tissue dise...
Introduction: So far no clinical or experimental evidences clearly explain how and which systemic sc...
BACKGROUND AND AIM: Fibrosing alveolitis develops in up to 80% of systemic sclerosis patients (SSc) ...
OBJECTIVES: Assessment of inflammatory activity in interstitial lung disease of systemic sclerosis (...
Inhaled 99mTc-DTPA alveolar clearance has previously shown to be abnormal in systemic sclerosis (SS...
The study investigated the characteristic of interstitial lung disease in a large series of systemic...
Background: Interstitial Lung Disease (ILD) is one of the major cause of morbidity and mortality in ...
AbstractPatients with scleroderma (systemic sclerosis—SSc) frequently develop an interstitial lung d...
Objective To prospectively investigate whether differences in pulmonary vasculature exist in systemi...
10noSystemic sclerosis (SSc) is an autoimmune disease, characterized by the presence of generalized ...
Purpose: to define clinical prognostic markers for evaluation of inflammation activity and prognosis...
Purpose: to define clinical prognostic markers for evaluation of inflammation activity and prognosis...
Objective Interstitial lung disease (ILD ) in systemic sclerosis (SS c) runs a highly variable cours...
Systemic sclerosis (SSc) is a complex, multiorgan, autoimmune disease. Lung fibrosis occurs in ∼80% ...
Purpose: to define clinical prognostic markers for evaluation of inflammation activity and prognosis...
Introduction and aim: Progressive systemic sclerosis (pSS) is a multisystemic connective tissue dise...
Introduction: So far no clinical or experimental evidences clearly explain how and which systemic sc...
BACKGROUND AND AIM: Fibrosing alveolitis develops in up to 80% of systemic sclerosis patients (SSc) ...
OBJECTIVES: Assessment of inflammatory activity in interstitial lung disease of systemic sclerosis (...
Inhaled 99mTc-DTPA alveolar clearance has previously shown to be abnormal in systemic sclerosis (SS...
The study investigated the characteristic of interstitial lung disease in a large series of systemic...
Background: Interstitial Lung Disease (ILD) is one of the major cause of morbidity and mortality in ...
AbstractPatients with scleroderma (systemic sclerosis—SSc) frequently develop an interstitial lung d...
Objective To prospectively investigate whether differences in pulmonary vasculature exist in systemi...
10noSystemic sclerosis (SSc) is an autoimmune disease, characterized by the presence of generalized ...
Purpose: to define clinical prognostic markers for evaluation of inflammation activity and prognosis...
Purpose: to define clinical prognostic markers for evaluation of inflammation activity and prognosis...
Objective Interstitial lung disease (ILD ) in systemic sclerosis (SS c) runs a highly variable cours...
Systemic sclerosis (SSc) is a complex, multiorgan, autoimmune disease. Lung fibrosis occurs in ∼80% ...
Purpose: to define clinical prognostic markers for evaluation of inflammation activity and prognosis...